11.99
+0.06
+(0.50%)
At close: January 24 at 4:00:01 PM EST
12.13
+0.14
+(1.17%)
Pre-Market: 7:52:13 AM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 2 | 7 | 7 |
| Avg. Estimate | 0.26 | 0.37 | 1.61 | 1.48 |
| Low Estimate | 0.14 | 0.28 | 1.46 | 1 |
| High Estimate | 0.33 | 0.46 | 1.75 | 1.89 |
| Year Ago EPS | 0.43 | 0.37 | 1.57 | 1.61 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 2 | 7 | 7 |
| Avg. Estimate | 260.43M | 266.15M | 1.15B | 1.07B |
| Low Estimate | 255M | 257.4M | 1.14B | 1.03B |
| High Estimate | 270M | 274.9M | 1.16B | 1.12B |
| Year Ago Sales | 293M | 284M | 1.09B | 1.15B |
| Sales Growth (year/est) | -11.11% | -6.29% | 5.17% | -6.73% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.28 | 0.41 | 0.4 | 0.41 |
| EPS Actual | 0.43 | 0.37 | 0.44 | 0.54 |
| Difference | 0.15 | -0.04 | 0.04 | 0.13 |
| Surprise % | 53.57% | -10.84% | 9.09% | 32.79% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.26 | 0.37 | 1.61 | 1.48 |
| 7 Days Ago | 0.26 | 0.37 | 1.63 | 1.59 |
| 30 Days Ago | 0.26 | 0.37 | 1.63 | 1.59 |
| 60 Days Ago | 0.43 | 0.4 | 1.63 | 1.59 |
| 90 Days Ago | 0.47 | 0.44 | 1.71 | 1.96 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | -- |
| Up Last 30 Days | -- | 1 | -- | -- |
| Down Last 7 Days | 2 | 1 | 1 | 1 |
| Down Last 30 Days | 3 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| INDV | -38.76% | 0.00% | 2.46% | -8.03% |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Upgrades & Downgrades
| Reiterates | Piper Sandler: Overweight to Overweight | 10/25/2024 |
| Maintains | Craig-Hallum: Buy to Buy | 10/11/2024 |
| Reiterates | Piper Sandler: Overweight to Overweight | 10/11/2024 |
| Reiterates | Piper Sandler: Overweight to Overweight | 9/13/2024 |
| Initiated | Piper Sandler: Overweight | 7/23/2024 |
| Maintains | Craig-Hallum: Buy to Buy | 7/10/2024 |
Related Tickers
IRWD Ironwood Pharmaceuticals, Inc.
3.7100
-1.59%
6785.TWO Alar Pharmaceuticals Inc.
126.00
+0.40%
PCRX Pacira BioSciences, Inc.
24.52
+5.10%
526075.BO 526075.BO,0P0000BXCE,0
4.5000
0.00%
LFCR Lifecore Biomedical, Inc.
6.32
+2.93%
6CQ.BE Cresco Labs Inc
0.8930
+1.13%
R9U2.F Green Thumb Industries Inc.
6.84
+2.63%
AX9.SG Akebia Therapeutics Inc
2.1460
-4.96%
HKMPF Hikma Pharmaceuticals PLC
26.64
0.00%
BON.SG Boiron SA
25.35
+0.60%